Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Punit Dhillon CEO, Co-founder Oncosec

  • Broadcast in Health



Follow This Show

If you liked this show, you should follow JustOncology.

On the Wednesday, November 6th 2013 broadcast at 2PM Pacific/5PM Eastern our special guest is Punit Dhillion who's making an encore appearance on our show. For more information on Punit click here and Oncosec here.

According to the Oncosec SEC filings, the company:

'..an emerging drug-medical device and therapeutic company focused on designing, developing and commercializing innovative and proprietary medical approaches for the treatment of solid tumors that have unmet medical needs or where currently approved therapies are inadequate based on their efficacy or side-effects.'

And from company website:

'Oncosec is a biotech company developing treatments for advanced-stage skin cancer. Our noninvasive therapies destroy solid tumors and metastatic cancer and preserve quality of life.'

Punit Dhillon is Co-founder, Director, President, and CEO of Oncosec. Prior to Oncosec he served as VP of finance and operations at Inovio Pharmaceuticals, Inc., Mr. Dhillon raised over $125 million through multiple financings and several licensing deals. He was also instrumental to the successful in-licensing of key intellectual property and a number of corporate transactions, including the acquisition and consolidation of Inovio AS, a Norwegian DNA delivery company, and the merger with VGX Pharmaceuticals.

Please join us for an informative chat.